Request Free Sample
×
Immuno Oncology Market
ID: MRFR/HC/35962-HCR
100 Pages
October 2025
Informe de investigación de mercado de inmunooncología por tipo de cáncer (cáncer de pulmón, melanoma, cáncer de mama, cáncer colorrectal, leucemia, linfoma), por modalidad de tratamiento (inhibidores de puntos de control, terapia celular adoptiva, vacunas contra el cáncer, virus oncolíticos, terapias dirigidas), por tipo de biomarcador (PD-1, PD-L1, CTLA-4, LAG-3, TIM-3, IDO), por terapias combinadas (combinaciones de inhibidores de puntos de control, Inhibidores de puntos de control y terapias dirigidas, inhibidores de puntos de control e ... leer más
Las empresas clave en el mercado Immuno Oncology Market incluyen
Alcance del informe
FAQs
What is the current valuation of the Immuno-Oncology Market as of 2024?
The Immuno-Oncology Market was valued at 125.69 USD Billion in 2024.
What is the projected market size for the Immuno-Oncology Market by 2035?
The market is projected to reach 333.7 USD Billion by 2035.
What is the expected CAGR for the Immuno-Oncology Market during the forecast period 2025 - 2035?
The expected CAGR for the Immuno-Oncology Market during 2025 - 2035 is 9.28%.
Which cancer types are leading in market valuation within the Immuno-Oncology sector?
Lung Cancer and Breast Cancer are leading, with valuations of 30.0 to 80.0 USD Billion and 25.0 to 70.0 USD Billion, respectively.
What are the key treatment modalities driving the Immuno-Oncology Market?
Checkpoint Inhibitors dominate the market, with a valuation range of 45.0 to 120.0 USD Billion.
How do combination therapies impact the Immuno-Oncology Market?
Combination therapies, particularly Targeted Therapy Combinations, are projected to reach 50.69 to 138.7 USD Billion.
Which biomarkers are most significant in the Immuno-Oncology Market?
PD-L1 and PD-1 are significant biomarkers, with valuations ranging from 30.0 to 80.0 USD Billion and 25.0 to 70.0 USD Billion, respectively.
What role do key players like Bristol-Myers Squibb and Merck & Co. play in the market?
Key players such as Bristol-Myers Squibb and Merck & Co. are instrumental in driving innovation and market growth.
What is the market outlook for advanced stage cancer treatments in Immuno-Oncology?
Advanced stage cancer treatments are expected to grow significantly, with a projected valuation of 50.0 to 130.0 USD Billion.
How does the Immuno-Oncology Market compare across different disease stages?
The market shows a strong focus on advanced and metastatic disease stages, with valuations of 50.0 to 130.0 USD Billion and 50.69 to 133.7 USD Billion, respectively.
Descargar muestra gratis
Complete el formulario a continuación para recibir una muestra gratuita de este informe
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Estudio de caso
Aerospace & Defense
Deja un comentario